RSC Chemistry Lectures 2005
Lamivudine is one of several nucleoside reverse transcriptase inhibitors indicated for the treatment of HIV/AIDS. This lecture investigates the development of synthesis in the enantioselective route of manufacture, and issues concerning solid state purity of the compound.
Date: 13 January 2005
Speaker: Mark Shipton (GlaxoSmithKline)
Venue: The Physics Lecture Theatre
Time: 4.00pm (refreshments served), lectures begin at 4.15pm
Contact Jeremy Ireland at the Chemistry Department via email: Jeremy.Ireland@warwick.ac.uk or tel: 02476 573821